Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Simone Schrodi
Observed names:
S Schrodi,
S. Schrodi,
Schrodi, Simone
Institutions:
Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit,
Ludwig-Maximilians-Universität München
Observed institutions:
LMU Klinikum,
München Klinik,
Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit,
Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie,
Ludwig-Maximilians-Universität München
ORCID:
0009-0007-1915-3524
Observed ORCID:
0009-0007-1915-3524
OpenAlex ID:
A5015706809
Outcome of breast cancer patients with low hormone receptor positivity: analysis of a 15-year population-based cohort
2021
·
S. Schrodi
, M. Braun
, et al.
·
Annals of Oncology
·
102
PDF
Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors – An analysis of 2765 patients from neoadjuvant clinical trials
2021
·
Sonia L. Villegas
, Valentina Nekljudova
, et al.
·
European Journal of Cancer
·
101
Surgical treatment of early stage breast cancer in elderly: an international comparison
2011
·
M. Kiderlen
, E. Bastiaannet
, et al.
·
Breast Cancer Research and Treatment
·
65
PDF
No Survival Benefit for Patients with Treatment in Certified Breast Centers-A Population-based Evaluation of German Cancer Registry Data
2015
·
Simone Schrodi
, Anett Tillack
, et al.
·
The Breast Journal
·
30
Role of postoperative radiotherapy in reducing ipsilateral recurrence in DCIS: an observational study of 1048 cases
2018
·
Stefanie Corradini
, Montserrat Pazos
, et al.
·
Radiation Oncology
·
22
PDF
Endocrine sensitivity is decisive for patient outcome in small node-negative breast cancers (BC) (pT1a,b) – Results from the Munich Cancer Registry
2014
·
T. Kolben
, N. Harbeck
, et al.
·
The Breast
·
21
Breast cancer: emerging principles of metastasis, adjuvant and neoadjuvant treatment from cancer registry data
2022
·
Jutta Engel
, Renate Eckel
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
12
PDF
A European, Observational Study of Endocrine Therapy Administration in Patients With an Initial Diagnosis of Hormone Receptor-Positive Advanced Breast Cancer
2017
·
Esther Bastiaannet
, Jackie Charman
, et al.
·
Clinical Breast Cancer
·
12
PDF
Veränderungen der Therapie des Mammakarzinoms in Bayern seit Einführung des Mammografie-Screenings. Eine Analyse bayerischer Krebsregisterdaten der Jahre 2000 bis 2008
2013
·
S. Schrodi
, U. Braisch
, et al.
·
Das Gesundheitswesen
·
11
Is primary surgery of breast cancer patients consistent with German guidelines? Twelve-year trend of population-based clinical cancer registry data
2014
·
S. Schrodi
, A. Niedostatek
, et al.
·
European Journal of Cancer Care
·
10
Validation of the 21-Gene Recurrence Score Assay in Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer and 0 to 3 Positive Lymph Nodes: Risk Pattern and Outcomes on a Community Level
2021
·
Michael Braun
, Antonia Kriegmair
, et al.
·
Breast Care
·
6
Treatment gaps and survival outcomes of hepatocellular carcinoma: insights from a nationwide, claims-based study
2025
·
Simone Schrodi
, Karin Berger-Thürmel
, et al.
·
Therapeutic Advances in Medical Oncology
·
5
Clinical, therapeutic and prognostic differences between male and female patients with breast cancer—a comparison of 2510 men and 307,634 women in a registry-based study in Germany
2025
·
Marion Graf
, Michael Gerken
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
3
PDF
Influence of breast cancer on life satisfaction in the elderly patient
2025
·
M. Burgmann
, K. Hermelink
, et al.
·
Archives of Gynecology and Obstetrics
·
3
PDF
Tastbefund an der Brust: Auch bei Männern immer abklären!
2017
·
Rachel Würstlein
, Andreas Hesse
, et al.
·
MMW - Fortschritte der Medizin
·
3
Tastbefund an der Brust: Auch bei Männern immer abklären!
2018
·
Rachel Würstlein
, Andreas Hesse
, et al.
·
Uro-News
·
2
Outcome von Mammakarzinom-Patientinnen in Abhängigkeit von molekularen Subtypen, definiert anhand von Surrogatparametern – Eine bevölkerungsbezogene Analyse von Krebsregisterdaten
2017
·
S Schrodi
, R Eckel
, et al.
·
Senologie - Zeitschrift für Mammadiagnostik und -therapie
·
2
Epidemiologie
2010
·
Jutta Engel
, Simone Schrodi
, et al.
·
Springer eBooks
·
2
What can claims data tell us about risk factors and survival of patients with hepatocellular carcinoma? Insights from a German population-based study
2025
·
Selina Becht
, Najib Ben Khaled
, et al.
·
Frontiers in Oncology
·
1
PDF
Breast cancer in patients under 40 years: an 11-year retrospective cohort analysis
2025
·
Franziska Ganster
, Simone Schrodi
, et al.
·
Archives of Gynecology and Obstetrics
·
1
PDF
195P Risk factors in patients with hepatocellular carcinoma: A German claims data analysis
2024
·
S. Becht
, K. Berger-Thürmel
, et al.
·
Annals of Oncology
·
1
PDF
Das Mammakarzinom des Mannes und der Frau: Eine vergleichende bevölkerungsbezogene Analyse eines 15-Jahres Kollektivs
2019
·
S Schrodi
, M Braun
, et al.
·
Senologie - Zeitschrift für Mammadiagnostik und -therapie
·
1
Tastbefund an der Brust: Auch bei Männern immer abklären!
2018
·
Rachel Würstlein
, Andreas Hesse
, et al.
·
Im Focus Onkologie
·
1
A real-world evidence study of patients with hormone receptor-positive locally advanced or metastatic breast cancer at primary diagnosis
2016
·
Esther Bastiaannet
, Jackie Charman
, et al.
·
European Journal of Cancer
·
1
Reply to Kowalski C, Wesselmann S, Kuhr K, Wallwiener D, & Kreienberg R
2015
·
Simone Schrodi
, Anett Tillack
, et al.
·
The Breast Journal
·
1
PDF
Show more works
View as search
Works count:
44
Citation count:
422
H-index:
10
I10-index:
10
Year
Topic
Type